# Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease

> **NCT03242499** · PHASE2 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Lovastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03242499
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-15
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2017-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03242499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03242499, "Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03242499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*